nf-logo
Leading NF Advocacy
Building NF Community

Highlighted Scientific Papers

When a group of local NF organizations started the National Neurofibromatosis Network organization, they set their sights high—to advance understanding of this little known disease, to create new treatments and knowledge of clinical management for individuals affected by Neurofibromatosis.

Continuous progress has been made toward these goals thanks to NF Network’s efforts to obtain federal dollars for NF research.  These funds have harnessed the best minds in science and recruited the finest research talent dedicated to Neurofibromatosis.

The list below is a highlight of NF scientific papers.

For the most current research news read The Network Edge which brings you regular updates on the latest neurofibromatosis (NF) research and clinical advances from recent scientific publications. 

Clinical Manifestations and Management of Neurofibromatosis Type 1 
James H. Tonsgard,MD

Primary Care for Patients with Neurofibromatosis 1  
Leigh Hart, RN, CCRN, PhD

Health Supervision for Children with Neurofibromatosis  
Joseph H. Hersh and Committee on Genetics Journal of the American Academy of Pediatrics

Do hormonal contraceptives stimulate growth of neurofibromas?
A survey on 59 NF1 patients. Marge Lammert, Victor-Felix Mautner, and Lan Kluwe

Superficial Neurofibroma: A Lesion with Unique MRI Characteristics in Patients with Neurofibromatosis Type 1
Ruth Lim, Diego Jaramillo, Tina Young Poussaint, Yuchiao Chang and Bruce Korf.

NF: Brain tumor study reveals why treatment efforts fail in genetic disorder
From Washington University School of Medicine

Neurofibromatous neuropathy in neurofibromatosis 1 (NF1).
Ferner RE, Hughes RA, Hall SM, Upadhyaya M, Johnson MR.

Social Skills of Children with NF1
Belinda Barton and Kathryn North

Neurofibromin Regulates Corticostriatal Inhibitory Networks during Working Memory Performance
Dept. of Neurobiology, University of California, Los Angeles

Molecular and Cellular Mechanisms of Learning Disabilities: A Focus on NF1
C. Shilyansky, Y.S. Lee and A.J. Silva

Phase I trial of pegylated interferon-α-2b in young patients with plexiform neurofibromas
R.I. Jakacki, E. Dombi, D.M. Potter, S. Goldman, J.C. Allen, I.F. Pollack, and B.C. Widemann

Practical Genetics: Neurofibromatosis 1
Rosalie E Ferner, Department of Neurology, Guy’s and St Thomas’ Hospitals, London, UK

Imatinib mesylate effectively treats children with neurofibromatosis type 1 tumors
Indiana University
 

Radiosurgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2: tumor control and hearing preservation
Phi JH, Kim DG, Chung HT, Lee J, Paek SH, Jung HW

The Neurofibromatosis 2 Protein, Merlin, Regulates Glial Cell Growth in an ErbB2- and Src-Dependent Manner
Houshmandi SS, Emnett RJ, Giovannini M, Gutmann DH

Treatment of progressive neurofibromatosis type 2-related vestibular schwannoma with erlotinib
Plotkin SR, Halpin CF, McKenna MJ, Batchelor TT, Loeffler JS, Barker FG

Merlin Is a Potent Inhibitor of Glioma Growth
Lau YKI, Murray LB, Houshmandi SS, Xu Y, Gutmann DH, Yu Q

CAPE (caffeic acid phenethyl ester)-based propolis extract (Bio 30) suppresses the growth of human neurofibromatosis (NF) tumor xenografts in mice
Demestre M, Messerli SM, Celli N, ShahhossinimM, Kluwe L, Mautner V, Maruta H

Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates
Mathieu D et al.

Neurofibromatosis Type 2 (NF2): A clinical and molecular view
D. Gareth R. Evans

Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients
Scott R. Plotkin, M.D., Ph.D., Caroline C. O’Donnell, B.A., R.N., William T. Curry Jr., M.D., Catherine M. Bove, M.Ed., A.P.N.G., Mia MacCollin, M.D., and Fabio P. Nunes, M.D.

Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function
Chunzhang Yang, Ashok R. Asthagiri, Rajiv R. Iyer, Jie Lu, David S. Xu, Alexander Ksendzovsky, Roscoe O. Brady, Zhengping Zhuang, and Russell R. Lonser

Following A Path To A Potential Therapy For NF2, A Rare Tumor Disorder
Source: Greg Lester, The Wistar Institute

Psychological distress in people with disfigurement from facial palsy
L. Fu, C. Bundy, and S. A. Sadiq

Hearing Resoration in Neurofibromatosis Type II Patients
Jeon Mi Lee, Jin Woo Chang, Jae Young Choi, Won Seok Chang, and In Seok Moon

Medical Journal Abstracts (Pub Med)
Enter search criteria (e.g. ‘NF1’ or ‘neurofibromatosis’) in the space provided.  Click “Search.”